Ovid Therapeutics Inc.
OVID- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636651
No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Ovid Therapeutics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 61 | 69 | +8 |
| Shares | 38.7M | 41.0M | +2.34M (+6.1%) |
| Value | $99.8M | $134.5M | +$34.7M (+34.8%) |
New holders (23)
Institutions that held Ovid Therapeutics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (15)
Institutions that held Ovid Therapeutics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Driehaus Capital Management LLC | 1,257,337 | $3.24M |
| Millennium Management LLC | 272,916 | $704.0K |
| Russell Investments Group, Ltd. | 267,459 | $690.0K |
| Jane Street Group, LLC | 108,615 | $280.2K |
| Boston Partners | 77,003 | $198.7K |
| Y-Intercept (Hong Kong) Ltd | 35,116 | $90.6K |
| Man Group plc | – | $71.6K |
| Balyasny Asset Management LLC | 24,056 | $62.1K |
| Cannell Capital LLC | 22,620 | $58.4K |
| Virtu Financial LLC | 17,892 | $46.0K |
| Mariner, LLC | 13,500 | $35.0K |
| Squarepoint Ops LLC | 11,271 | $29.1K |
| Point72 Middle East FZE | 5,993 | $15.5K |
| Cubist Systematic Strategies, LLC | 5,155 | $13.3K |
| Simplex Trading, LLC | 422 | $1.00K |